Biotech Archives - Boston Life Sciences Times

How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences

January 6, 2026

Foray Bioscience Secures First Fabricated Seed Partnership With West Coast Chestnut

January 5, 2026

instED Names Don Stiffler Chief Executive Officer

December 29, 2025

THIS WEEK'S STORIES

Viz.ai Names Dr. Timothy N. Showalter as Its First Chief Medical Officer

January 6, 2026

AstraZeneca Names Rick R. Suarez US President and Head of US BioPharmaceuticals Unit

January 8, 2026

Alkermes’ Alixorexton Receives FDA Breakthrough Therapy Designation for Narcolepsy Type 1

January 6, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

VectorY Therapeutics’ VTx-002 Granted FDA Fast Track Designation for ALS

Cellino and Polyphron Partner to Scale Personalized Tissue Replacement Manufacturing

BostonGene Partners With Ottimo Pharma to Advance AI-Guided Development of PD-1/VEGFR2 Cancer Therapy

Ascidian Therapeutics and Forge Biologics Partner to Advance RNA Editing Therapy for Stargardt Disease

DEM BioPharma to Present Preclinical Data on DEM301 at 2026 ASCO Gastrointestinal Cancers Symposium

Most Read

ZOLL Launches Next-Generation LifeVest Wearable Defibrillator in U.S.

Allotex Receives FDA Clearance to Begin U.S. Clinical Study for Presbyopia Device

VectorY Therapeutics’ VTx-002 Granted FDA Fast Track Designation for ALS

Carna Health Raises $8 Million to Expand Global Chronic Kidney Disease Screening Programs

EDITOR PICKS

How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences

Foray Bioscience Secures First Fabricated Seed Partnership With West Coast Chestnut

instED Names Don Stiffler Chief Executive Officer

THIS WEEK'S STORIES

Viz.ai Names Dr. Timothy N. Showalter as Its First Chief Medical Officer

AstraZeneca Names Rick R. Suarez US President and Head of US BioPharmaceuticals Unit

Alkermes’ Alixorexton Receives FDA Breakthrough Therapy Designation for Narcolepsy Type 1

POPULAR CATEGORY

ABOUT US

FOLLOW US